Antibody-dependent enhancement and COVID-19: Moving toward acquittal.

• Immunoglobulins represent an effective therapeutic option for the treatment of COVID-19. • Experimental findings of ADE with related coronaviruses provoked theoretical concerns of enhancing antibodies with COVID-19. • Emerging experimental and clinical data alleviate concerns and indorse the safety of antibody-based therapies for COVID-19.